semaglutide increased heart rate Benefits Diabetic Patients Regardless of CVD Status: FLOW Subanalysis increased heart rate with GLP1

Fatigue: Some participants reported fatigue, particularly during the early titration period

Now that we understand the health risks of obesity, we know that this chronic disease requires lifelong treatment. Consider This When Preparing to Stop Weight-Loss Drugs Some people opt to stop taking weight-loss medications because of their side effects, which can include nausea, diarrhea and constipation

Transition strategies include gradually increasing portion sizes to test your natural hunger signals, practicing mindful eating techniques that help you recognize true hunger versus habitual eating, and maintaining the protein-first approach even after appetite returns to pre-medication levels

Your provider can recommend the best alternative based on your medical history and tolerance profile

New England Journal of Medicine, 387 (3), 205-216

The shortage list removal Tirzepatide was removed from the FDA drug shortage list on October 2, 2024